Events List‎ > ‎

ETH Professor and Alumni on a panel on Nanotechnology and Venture Creation at swissnex

Dear ETH Alumnus
 
We would like to invite you to a short lecture, followed by a panel discussion on the topic of nanotechnology and venture creation with two unique guests having close ties to ETHZ
 
When: Tuesday, April 12, 6.15 – 8.00 pm
 
Where: swissnex Boston, 420 Broadway, Cambridge, MA 02138
 
What: two excellent speakers will outline the challenges and differences faced by academics and entrepreneurs in taking discoveries in the field of nanotechnology from the laboratory and commercialize them. The panel will compare and contrast their experiences in venture creation in Switzerland and in the US:
 
- Prof. Wendelin Stark is the director of the Functional Materials Laboratory at ETH Zürich as well as co-founder of Turbobeads GmbH and Nanograde GmbH. He is currently on a sabbatical in the department of Chemical Engineering at MIT. Please find below the full bios.
 
- Dr. Marc Rioult is a Technology Licensing Officer at MIT. He develops strategies and manages IP in the fields of life sciences, bioengineering and chemistry. 
 
The panel will be moderated by Patrick Anquetil, Board member of the ETH Alumni NEC and co-founder of SynapDx a Boston-based medical diagnostic company. After the discussion a little mixer will assure a good interaction among the guests and speakers.
 
Please RSVP here by Friday April 8 if you are planning to join the event.
 
 
Bios:

Professor Dr. Wendelin J. Stark, ETH Zurich

Wendelin Stark (1976, Swiss) has founded the Functional Materials Laboratory at ETH Zürich in 2004. His research is situated at the interface between nanomaterials, chemistry and biology and tight collaborations with clinical groups focus on application-oriented development. This approach has resulted in two commercialized processes (> 250 Mio. sold units per year), an extended preclinical test phase of an injectable and resorbable bone wool and elucidation of two mechanisms in nanotoxicology. He has currently published 120 research articles in top peer reviewed journals and holds 20 patents.
 
W. Stark is co-founder of 3 spin-off companies (1 gone; 2 alive). Turbobeads GmbH globally sells nanomagnets for diagnostic, magnetic chemistry and water purification. Nanograde GmbH offers over 1 Million nanoparticles of different composition and allows user to rapidly access customized nanoproducts.
 
Professor Stark is one of the former Chairmen of the largest conference on nanotoxicology (International Conference on Nanotoxicology; Sept. 2008) and serves on numerous committees with governmental and industrial background involved in the development of safe nanomaterials.

Dr. Marc Rioult, Technology Licensing officer, MIT
 
Marc G. Rioult has been involved in technology transactions and in the facilitation of startup creation for over ten years. While working mainly in the life and medical sciences, he has also experience in nanotechnologies, electronics, software, chemical technologies, microfluidics, and consumer products.  Before joining MIT, he worked consecutively for two consulting companies engaged both in technology acquisition and commercialization, mostly for Fortune 500 clients. Prior to this, he co-managed a software startup for two years after leaving academic research in neuroscience. Dr. Rioult has a Ph.D. in neuroscience from the Federal Institute of Technology (ETH) in Zurich, and an executive MBA from Boston University. 
 
Dr. Patrick Anquetil, SynapDx

Patrick is a co-founder of SynapDx and Aretais, two Boston-based medical diagnostics startups. Prior, Patrick was a science and nanotechnology equity research analyst at Susquehanna International Group.  He received a PhD from MIT in Bio-Instrumentation, an MBA from Harvard Business School and a Master's degree from the ETH in Zurich.
Comments